Melander Maria C, Jürgensen Henrik J, Madsen Daniel H, Engelholm Lars H, Behrendt Niels
The Finsen Laboratory, Rigshospitalet/BRIC, The University of Copenhagen, DK-2200 Copenhagen N, Denmark.
Proteases and Tissue Remodeling Section, Oral and Pharyngeal Cancer Branch, NIDCR, National Institutes of Health, Bethesda, MD, USA.
Int J Oncol. 2015 Oct;47(4):1177-88. doi: 10.3892/ijo.2015.3120. Epub 2015 Aug 12.
The collagen receptor uPARAP/Endo180, the product of the MRC2 gene, is a central component in the collagen turnover process governed by various mesenchymal cells. Through the endocytosis of collagen or large collagen fragments, this recycling receptor serves to direct basement membrane collagen as well as interstitial collagen to lysosomal degradation. This capacity, shared only with the mannose receptor from the same protein family, endows uPARAP/Endo180 with a critical role in development and homeostasis, as well as in pathological disruptions of the extracellular matrix structure. Important pathological functions of uPARAP/Endo180 have been identified in various cancers and in several fibrotic conditions. With a particular focus on matrix turnover in cancer, this review presents the necessary background for understanding the function of uPARAP/Endo180 at the molecular and cellular level, followed by an in-depth survey of the available knowledge of the expression and role of this receptor in various types of cancer and other degenerative diseases.
胶原蛋白受体uPARAP/Endo180是MRC2基因的产物,是各种间充质细胞调控的胶原蛋白周转过程中的核心成分。通过胶原蛋白或大的胶原蛋白片段的内吞作用,这种循环受体将基底膜胶原蛋白以及间质胶原蛋白导向溶酶体降解。这种仅与同一蛋白家族的甘露糖受体共有的能力,赋予uPARAP/Endo180在发育、内环境稳定以及细胞外基质结构的病理破坏中发挥关键作用。在各种癌症和几种纤维化疾病中已确定uPARAP/Endo180具有重要的病理功能。本文特别关注癌症中的基质周转,介绍了在分子和细胞水平上理解uPARAP/Endo180功能所需的背景知识,随后深入探讨了该受体在各种类型癌症和其他退行性疾病中的表达及作用的现有知识。